Net profit of Fortis Healthcare rose 1.58% to Rs 176.46 crore in the quarter ended September 2024 as against Rs 173.72 crore during the previous quarter ended September 2023. Sales rose 12.34% to Rs 1988.39 crore in the quarter ended September 2024 as against Rs 1769.95 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1988.391769.95 12 OPM %21.8718.65 - PBDT415.87313.14 33 PBT320.82229.02 40 NP176.46173.72 2 Powered by Capital Market - Live News

Fortis Healthcare will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live News

The Board of Fortis Healthcare at its meeting held on 09 October 2024 has approved the issuance of listed, senior, secured, rated, redeemable Non-Convertible Debenture (NCDs) aggregating for a value of up to Rs 1550 crore having a face value of Rs. 1,00,000 on private placement basis to the eligible investors. Powered by Capital Market - Live News

Fortis Healthcare will hold a meeting of the Board of Directors of the Company on 9 October 2024Powered by Capital Market - Live News

The Board of Fortis Healthcare will meet on 09 October 2024 to consider fund raising by way of NCD issuance. Powered by Capital Market - Live News